Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > AOD 9604 for Sale > AOD, Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - large image1
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - image1
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - image2
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - image3
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - image4
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - image5
AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid buy - image6

AOD, Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid

TDS

Unit Price:

$103/UNIT FOB

Get Latest Price
CAS No.:

386264-39-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hongkong

Brand:

Novio

Packaging:

5mg*10vials, 10mg*10vials

Sample Available:

Yes

Price valid (until):

2026-10-20

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    WhatsApp +852 9339 8574
    AOD is a small-molecule peptide derived from a specific segment of natural growth hormone and serves as a candidate substance in the field of metabolic regulation research. Rather than being the full hormone, it is a synthetically optimized version comprising only the key functional fragment associated with lipid metabolism. This design allows AOD to retain the activity characteristics linked to energy metabolism regulation while avoiding the complex, multifaceted effects associated with the complete hormone, thereby establishing a unique position in metabolic research. Driven by the concept of "precise targeting and directed regulation," AOD has consistently attracted attention in the fields of metabolic science, weight management, and exercise science, with its potential value undergoing continuous evaluation as research deepens.
    In terms of its mechanism of action, AOD’s core function lies in the regulation of lipid metabolism. The body relies on sugars and fats as its two primary energy sources; the balance and coordination between them directly influence energy supply and storage. AOD participates in regulating the process of lipolysis (fat breakdown), facilitating the conversion of stored fat into usable energy and thereby optimizing the balance between energy supply and expenditure. Research indicates that AOD primarily targets lipid metabolism, enhancing the body's efficiency in utilizing fat and helping to reduce the long-term accumulation of excess adipose tissue. This mechanism of "lipid-focused, directed regulation" gives it a distinct, targeted role in metabolic regulation research.
    AOD demonstrates significant value in the optimization of energy metabolism. The body's energy balance depends on the coordination between intake and expenditure, with the breakdown and utilization of fat serving as a crucial component of energy expenditure. By regulating lipid metabolism, AOD helps enhance energy expenditure efficiency under specific conditions and optimizes the ratio of energy derived from sugars versus fats. Relevant studies often associate AOD with favorable changes in lipid metabolism markers, highlighting its potential to improve the overall state of energy metabolism. This mechanism, which focuses on the deep regulation of energy balance, distinguishes it from superficial interventions that merely suppress intake, reflecting a more comprehensive understanding of metabolic regulation.
    AOD continues to garner attention in the field of weight management research. Successful weight management hinges on establishing and maintaining a healthy balance between energy intake and expenditure, whereas fat accumulation is often a direct manifestation of energy imbalance. By promoting lipolysis and optimizing energy utilization, AOD provides metabolic-level support for weight management, helping to further enhance fat metabolism efficiency when combined with a balanced diet and regular exercise. Naturally, AOD is not a substitute for a healthy lifestyle but rather serves as a metabolic-level supplement to it. This positioning—as an aid rather than a replacement—establishes a logical basis for its use in weight management research.
    In terms of application characteristics, AOD—a synthetic derivative peptide—offers distinct advantages: a well-defined structure, controllable purity, and relatively focused action. Derived from a specific fragment of growth hormone, it has been optimized for stability, facilitating standardized research and development. Furthermore, its mechanism is relatively focused on lipid metabolism with clear targeting, allowing for precise study design and evaluation. These characteristics—clarity, focus, and controllability—make it highly suitable for specific areas of metabolic research and provide a foundation for further exploration.
    Regarding safety, it is important to view the current status of AOD objectively. As a research-grade peptide, AOD is primarily used in laboratory studies, metabolic science exploration, and related product development; it has not yet received full regulatory approval or market launch as a mature product globally. Its observed effects stem largely from studies conducted under specific conditions, and actual outcomes depend heavily on factors such as dosage and individual physiological status. Therefore, any research or application must be grounded in thorough understanding and standardized assessment, adhering to scientific principles to avoid indiscriminate use. Research teams continue to conduct evaluations to refine the understanding of its effects and impact.
    From an industry perspective, AOD represents a research direction focused on "targeted regulation via precise fragments." Its approach—combining the targeting capabilities of natural functional fragments with the stability of synthetic peptides—offers a fresh perspective on metabolic regulation research. Unlike compounds with broad actions or complex mechanisms, AOD aligns with modern metabolic research's pursuit of precision, thanks to its clearly defined origins, focused targeting, and gentle action. With advancements in metabolomics and synthetic peptide technology, the potential value of AOD in areas such as lipid metabolism regulation is poised for further evaluation and exploration.
    Of course, there is still much to explore regarding AOD. Questions such as individual variations in response, long-term effects, and interactions with other active substances remain to be addressed in future research. The regulation of lipid metabolism involves the complex coordination of multiple mechanisms, and the specific role played by AOD within this context requires further clarification through robust evidence. Only by conducting thorough research and establishing a solid body of evidence can its application value and prospects be accurately assessed; this process reflects the fundamental principles of scientific inquiry, which prioritize a step-by-step approach grounded in evidence.
    Overall, AOD demonstrates unique value in the fields of metabolic regulation and energy balance research, owing to its ability to specifically modulate lipid metabolism, as well as its well-defined origin, structural stability, and targeted mode of action. It serves not only as a significant subject for understanding the mechanisms of lipid metabolism regulation but also offers a promising avenue for exploring gentle yet precise approaches to metabolic management. By promoting lipolysis, optimizing energy utilization, and aiding in weight management, AOD opens up new perspectives for research into metabolic health and provides a vital reference and foundation for the future development of related products.

    Items Specifications
    Product Name AOD
    Appearance White lyophilized powder
    Purity 99%
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 1
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 2
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 3
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 4
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 5
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 6
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 7
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 8
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 9
    Shop AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid-Detailed Image 10
    ECHEMI Editorial Reference
    sh-Oligopeptide-74 is a protein fragment which contains 16 amino acids and is produced synthetically to be identical to a fragment of the human protein, Somatropin. The fragment consists of the proper sequence of the 20 standard amino acids.

    Certificates
    • AOD,  Synthetic Peptide, Growth Hormone Fragment Peptide, Lipid Metabolism Peptide, Energy Metabolism Regulation, Fat-Burning Peptide, Research Peptid Certificates 1 TDS

    Basic Info
    Product Name:

    AOD 9604

    CAS No.:

    386264-39-7

    Molecular Formula:

    C78H125N23O23S2

    Molecular Weight:

    1817.0974

    Research
    Class:

    Synthetic hGH fragment 177–191 (lipolytic peptide, 15-amino-acid cyclic)

    Status:

    Research compound — Not FDA approved. Phase 2b obesity trials completed, not advanced.

    Mechanism:

    A synthetic 15-amino-acid peptide (Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, cyclized via Cys-Cys disulfide bond) derived from the C-terminal region (amino acids 177–191) of human growth hormone. AOD-9604 mimics the fat-metabolizing domain of hGH without stimulating IGF-1 or cell proliferation. It stimulates lipolysis via β3-adrenergic receptors and inhibits lipogenesis, producing selective fat reduction.

    Activity note:

    AOD-9604 is a lipolytic peptide fragment, not a traditional receptor agonist. Functional lipolytic activity is observed at micromolar concentrations in adipocyte assays. Does not bind GHR.

    Source:

    Ng FM, et al. J Endocrinol. 2000;165(3):595–605. Heffernan MA, et al. Am J Physiol Endocrinol Metab. 2000;279(3):E501–E507.DOI

    Clinical Development:

    ACTRN12605000111673

    References
    PubChem:

    PubChem

    Disclaimer:

    AOD-9604 is NOT FDA-approved or EMA-approved. Phase 2b clinical trials for obesity were completed but the program was not advanced to Phase 3. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Cosmetic Raw Materials,Pharmaceutical Intermediates

    Location:

    Room 1359, Room 103, Building Jia 19, Jixiang Garden, Tongzhou District, Beijing

    Year of Establishment:

    2026

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.